Agios Pharmaceuticals AGIO Stock
27.14 USD
{{ price }}
-2.444286%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
1.56B USD
LOW - HIGH [24H]
26.93
-
27.74 USD
VOLUME [24H]
548.65K USD
{{ volume }}
P/E Ratio
2.33
Earnings per share
11.64 USD
Agios Pharmaceuticals Price Chart
Agios Pharmaceuticals AGIO Financial and Trading Overview
| Agios Pharmaceuticals stock price | 27.14 USD |
| Previous Close | 25.73 USD |
| Open | 25.55 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1000 |
| Day's Range | 25.15 - 25.9 USD |
| 52 Week Range | 17.38 - 34.76 USD |
| Volume | 470.02K USD |
| Avg. Volume | 452.15K USD |
| Market Cap | 1.43B USD |
| Beta (5Y Monthly) | 0.940492 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 11.64 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 37.4 USD |
AGIO Valuation Measures
| Enterprise Value | 819.36M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.692727 |
| PEG Ratio (5 yr expected) | -0.11 |
| Price/Sales (ttm) | 75.43463 |
| Price/Book (mrq) | 1.3830242 |
| Enterprise Value/Revenue | 43.086 |
| Enterprise Value/EBITDA | -2.211 |
Trading Information
Agios Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.940492 |
| 52-Week Change | 43.62% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 34.76 USD |
| 52 Week Low | 17.38 USD |
| 50-Day Moving Average | 24.5 USD |
| 200-Day Moving Average | 26.98 USD |
AGIO Share Statistics
| Avg. Volume (3 month) | 452.15K USD |
| Avg. Daily Volume (10-Days) | 407.37K USD |
| Shares Outstanding | 55.58M |
| Float | 51.4M |
| Short Ratio | 12.25 |
| % Held by Insiders | 1.35% |
| % Held by Institutions | 109.02% |
| Shares Short | 5.74M |
| Short % of Float | 10.44% |
| Short % of Shares Outstanding | 10.31% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1990.40% |
| Gross Margin | 104.74% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -19.023% |
| Return on Equity (ttm) | -19.43% |
Income Statement
| Revenue (ttm) | 19.02M USD |
| Revenue Per Share (ttm) | 0.35 USD |
| Quarterly Revenue Growth (yoy) | 574.20% |
| Gross Profit (ttm) | 12.54M USD |
| EBITDA | -370639008 USD |
| Net Income Avi to Common (ttm) | -218044992 USD |
| Diluted EPS (ttm) | -4.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 739.2M USD |
| Total Cash Per Share (mrq) | 13.3 USD |
| Total Debt (mrq) | 82.34M USD |
| Total Debt/Equity (mrq) | 7.94 USD |
| Current Ratio (mrq) | 17.548 |
| Book Value Per Share (mrq) | 18.662 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -306926016 USD |
| Levered Free Cash Flow (ttm) | -190762880 USD |
Profile of Agios Pharmaceuticals
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 88 Sidney Street |
| ZIP | 02139 |
| Phone | 617 649 8600 |
| Website | https://www.agios.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 389 |
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism. The company develops PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias; and AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Q&A For Agios Pharmaceuticals Stock
What is a current AGIO stock price?
Agios Pharmaceuticals AGIO stock price today per share is 27.14 USD.
How to purchase Agios Pharmaceuticals stock?
You can buy AGIO shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Agios Pharmaceuticals?
The stock symbol or ticker of Agios Pharmaceuticals is AGIO.
Which industry does the Agios Pharmaceuticals company belong to?
The Agios Pharmaceuticals industry is Biotechnology.
How many shares does Agios Pharmaceuticals have in circulation?
The max supply of Agios Pharmaceuticals shares is 57.3M.
What is Agios Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Agios Pharmaceuticals PE Ratio is 2.33161500 now.
What was Agios Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Agios Pharmaceuticals EPS is 11.64 USD over the trailing 12 months.
Which sector does the Agios Pharmaceuticals company belong to?
The Agios Pharmaceuticals sector is Healthcare.
Agios Pharmaceuticals AGIO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16307.16 USD — |
-3.07
|
7.08B USD — | 16066.46 USD — | 16600.37 USD — | — - | 7.08B USD — |
| Dow Jones U.S. Biotechnology In DJUSBT | 2441.52 USD — |
-1.85
|
96.49M USD — | 2426 USD — | 2494.44 USD — | — - | 96.49M USD — |
| NASDAQ Composite Total Return I XCMP | 19961.28 USD — |
-3.07
|
— — | 19666.65 USD — | 20320.18 USD — | — - | — — |
| Nasdaq US 700 Small Cap Value I NQUS700SCV | 1794.43 USD — |
-0.83
|
— — | 1776.95 USD — | 1815.24 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7975.27 USD — |
-3.09
|
— — | 7857.2 USD — | 8119.29 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 3931.86 USD — |
-1.96
|
— — | 3898 USD — | 4000.18 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 882.43 USD — |
-1.77
|
— — | 875.25 USD — | 895.82 USD — | — - | — — |
| NASDAQ Global BuyBack Achievers DRBG | 2138.2 USD — |
-0.56
|
— — | 2131.06 USD — | 2157.07 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4254.21 USD — |
-1.96
|
— — | 4217.56 USD — | 4328.12 USD — | — - | — — |
| Nasdaq US 700 Small Cap Value N NQUS700SCVN | 2019.54 USD — |
-0.83
|
— — | 1999.87 USD — | 2042.96 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 1966.83 USD — |
-0.91
|
— — | 1943.77 USD — | 1985.27 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ US BuyBack Achievers Sel DRBS | 2340.09 USD — |
+0.42
|
— — | 2336.31 USD — | 2349.71 USD — | — - | — — |
- {{ link.label }} {{link}}